山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2014年
43期
16-18
,共3页
李彬%卢成志%夏大胜%赵剑%张峰%李超
李彬%盧成誌%夏大勝%趙劍%張峰%李超
리빈%로성지%하대성%조검%장봉%리초
冠状动脉性心脏病%血小板CD40配体%组织因子%组织因子途径抑制物
冠狀動脈性心髒病%血小闆CD40配體%組織因子%組織因子途徑抑製物
관상동맥성심장병%혈소판CD40배체%조직인자%조직인자도경억제물
coronary heart disease%platelet CD40 ligand%tissue factor%tissue factor pathway inhibitor
目的:观察早发冠心病患者的血小板CD40配体( CD40 L)表达变化并探讨其意义。方法因胸闷、胸痛而接受冠状动脉造影的患者200例,造影显示冠状动脉狭窄140例(早发冠心病组)、冠状动脉无狭窄60例(对照组)。采用流式细胞技术测定血小板CD40 L平均荧光强度, ELISA法检测血浆组织因子( TF)及组织因子途径抑制物(TFPI)。结果早发冠心病组血小板CD40L荧光强度为(19.3±6.1)a.u,血浆TF为(70.0±9.5)ng/L、TFPI为(68.0±9.4)μg/L、TF/TFPI为1.3±0.1,对照组分别为(8.8±2.4)a.u、(55.3±7.5)ng/L、(59.3±7.7)μg/L、0.9±0.1,两组相比,P<0.05或P<0.01;血小板CD40 L荧光强度与早发冠心病患者血浆TF、TFPI、TF/TFPI均呈正相关(r分别为0.43、0.32、0.30,P均<0.01);血小板CD40L荧光强度与早发冠心病患者血浆TF水平呈独立正相关(B=0.4,P<0.01)、与早发冠心病发病呈独立正相关(B=0.8,P<0.01)。结论早发冠心病患者血小板CD40 L表达增强,高CD40 L水平可能通过促进TF的表达而促进早发冠心病的发生发展。
目的:觀察早髮冠心病患者的血小闆CD40配體( CD40 L)錶達變化併探討其意義。方法因胸悶、胸痛而接受冠狀動脈造影的患者200例,造影顯示冠狀動脈狹窄140例(早髮冠心病組)、冠狀動脈無狹窄60例(對照組)。採用流式細胞技術測定血小闆CD40 L平均熒光彊度, ELISA法檢測血漿組織因子( TF)及組織因子途徑抑製物(TFPI)。結果早髮冠心病組血小闆CD40L熒光彊度為(19.3±6.1)a.u,血漿TF為(70.0±9.5)ng/L、TFPI為(68.0±9.4)μg/L、TF/TFPI為1.3±0.1,對照組分彆為(8.8±2.4)a.u、(55.3±7.5)ng/L、(59.3±7.7)μg/L、0.9±0.1,兩組相比,P<0.05或P<0.01;血小闆CD40 L熒光彊度與早髮冠心病患者血漿TF、TFPI、TF/TFPI均呈正相關(r分彆為0.43、0.32、0.30,P均<0.01);血小闆CD40L熒光彊度與早髮冠心病患者血漿TF水平呈獨立正相關(B=0.4,P<0.01)、與早髮冠心病髮病呈獨立正相關(B=0.8,P<0.01)。結論早髮冠心病患者血小闆CD40 L錶達增彊,高CD40 L水平可能通過促進TF的錶達而促進早髮冠心病的髮生髮展。
목적:관찰조발관심병환자적혈소판CD40배체( CD40 L)표체변화병탐토기의의。방법인흉민、흉통이접수관상동맥조영적환자200례,조영현시관상동맥협착140례(조발관심병조)、관상동맥무협착60례(대조조)。채용류식세포기술측정혈소판CD40 L평균형광강도, ELISA법검측혈장조직인자( TF)급조직인자도경억제물(TFPI)。결과조발관심병조혈소판CD40L형광강도위(19.3±6.1)a.u,혈장TF위(70.0±9.5)ng/L、TFPI위(68.0±9.4)μg/L、TF/TFPI위1.3±0.1,대조조분별위(8.8±2.4)a.u、(55.3±7.5)ng/L、(59.3±7.7)μg/L、0.9±0.1,량조상비,P<0.05혹P<0.01;혈소판CD40 L형광강도여조발관심병환자혈장TF、TFPI、TF/TFPI균정정상관(r분별위0.43、0.32、0.30,P균<0.01);혈소판CD40L형광강도여조발관심병환자혈장TF수평정독립정상관(B=0.4,P<0.01)、여조발관심병발병정독립정상관(B=0.8,P<0.01)。결론조발관심병환자혈소판CD40 L표체증강,고CD40 L수평가능통과촉진TF적표체이촉진조발관심병적발생발전。
Objective To explore variation and effect of the expression of CD 40 ligand(CD40L) on platelets in prema-ture coronary heart disease patients .Methods Selected 200 patients experienced coronary artery angiography due to chest congestion or pain as experimental subjects , which were divided as premature coronary heart disease group ( 140 cases of coronary artery stenosis shown on imaging ) and control group ( 60 cases without stenosis ) .Flow cytometry was used for measurement of mean fluorescence intensity about CD 40 L on platelets.Tissue factor (TF) and tissue factor pathway inhibi-tor ( TFPI) were detected by method of ELISA .Results In premature coronary heart disease group , the data of fluores-cence intensity[(19.3 ±6.1) a.u],TF in plasma[(70.0 ±9.5) ng/L],TFPI[(68.0 ±9.4)μg/L], TF/TFPI(1.3 ± 0.1) were collected.Furthermore, the figures were detected as(8.8 ±2.4) a.u,(55.3 ±7.5)ng/L,(59.3 ±7.7)μg/L, (0.9 ±0.1 ) in control group correspondingly .There was significant difference between two groups ( P<0.05 or P <0.01).It had revealed positive correlation between fluorescence intensity of CD 40L on platelets and TF in plasma, TFPI, TF/TFPI of premature coronary heart disease patients (r were 0.43, 0.32, 0.30;all P<0.01).In addition, fluorescence intensity of CD40L on platelets was independenty positive correlated with TF level in plasma (B=0.4, P<0.01) and onset (B=0.8, P<0.01) of premature coronary heart disease.Conclusions The expression of platelet CD40L shows an in-creasing trend in premature coronary heart disease patients .Besides, high level of CD40 L may accelerate the occurrence and development of premature coronary heart disease by stimulating the expression of TF .